CERTARA INC. - COMMON STOCK

Certara Completes Acquisition of Chemaxon

02 أكتوبر 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Certara’s Simcyp Consortium Celebrates 25th Anniversary

24 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

18 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

21 أغسطس 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Certara Launches Phoenix™ Version 8.5 Drug Development Software

15 أغسطس 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Certara Reports Second Quarter 2024 Financial Results

06 أغسطس 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

09 يوليو 2024 16:45:00 بحسب Nasdaq GlobeNewswire

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

02 يوليو 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

17 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Certara to Participate in the Jefferies Global Healthcare Conference

29 مايو 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Certara Appoints New Chief Human Resources Officer & General Counsel

21 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Certara Reports First Quarter 2024 Financial Results

07 مايو 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

16 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Certara Reports Fourth Quarter 2023 Financial Results

29 فبراير 2024 16:10:01 بحسب Nasdaq GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

01 فبراير 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

13 ديسمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  

21 نوفمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Certara Reports Third Quarter 2023 Financial Results

08 نوفمبر 2023 16:10:01 بحسب Nasdaq GlobeNewswire

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

11 أكتوبر 2023 16:15:00 بحسب Nasdaq GlobeNewswire

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

19 سبتمبر 2023 08:15:00 بحسب Nasdaq GlobeNewswire